Raymond de Vre
Vorsitzender bei PolyPeptide Laboratories A/S
Vermögen: 429 574 $ am 31.05.2024
Profil
Raymond de Vre is currently the Chairman at PolyPeptide Laboratories A and a Director at Aurigene Discovery Technologies Ltd.
He was previously the Chief Executive Officer at PolyPeptide Group AG from 2021 to 2023 and a Partner at McKinsey & Co., Inc. from 2004 to 2011.
Dr. de Vre holds a doctorate degree from Stanford University and a graduate degree from Université Libre de Bruxelles.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG
0,04% | 31.12.2023 | 11 603 ( 0,04% ) | 429 574 $ | 31.05.2024 |
Aktive Positionen von Raymond de Vre
| Unternehmen | Position | Beginn |
|---|---|---|
Aurigene Discovery Technologies Ltd.
 Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Direktor/Vorstandsmitglied | - |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Vorsitzender | - |
Ehemalige bekannte Positionen von Raymond de Vre
| Unternehmen | Position | Ende |
|---|---|---|
| POLYPEPTIDE GROUP AG | Vorstandsvorsitzender | 30.01.2023 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Raymond de Vre
| Stanford University | Doctorate Degree |
| Université Libre de Bruxelles | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| POLYPEPTIDE GROUP AG | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Process Industries |
